Edward Jones Tops $63M in Alzheimer's Research Funding as Alliance Extends to 2030
Event summary
- Edward Jones and the Alzheimer's Association have raised over $63M since 2016, with nearly $12M directed to research.
- The alliance, extended through 2030, includes support for caregiver resources and advocacy efforts.
- Edward Jones' Diamond National Team has already raised over $2M toward its $3.75M annual Walk to End Alzheimer's goal.
- The firm promotes Carefull, a financial safety platform, to protect against fraud for clients with cognitive decline.
The big picture
Edward Jones' long-term commitment to Alzheimer's research and caregiver support aligns with broader industry trends in ESG investing and financial wellness. With $2.6T in AUM, the firm's strategic alliance reflects a growing recognition of healthcare's intersection with long-term financial planning. The partnership also underscores the rising demand for solutions addressing cognitive decline and fraud protection in an aging population.
What we're watching
- Fundraising Momentum
- Whether Edward Jones can sustain its record-breaking fundraising pace, particularly as Alzheimer's cases are projected to nearly double by 2050.
- Policy Advocacy
- How the firm's push for caregiver-focused legislation, such as the Improving Retirement Security for Family Caregivers Act, impacts public policy.
- Research Impact
- The pace at which the $12M in research funding translates into tangible breakthroughs, particularly in the U.S. POINTER Trial and DIAN-TU initiatives.
Related topics